Diabetes drug tested to ease harsh side effects of thyroid cancer therapy
NCT ID NCT03109847
Summary
This small, terminated study tested whether the common diabetes drug metformin could help reduce side effects for people with thyroid cancer undergoing radioactive iodine treatment. The goal was to see if metformin could protect blood cell counts and lessen symptoms like dry mouth, dry eyes, and taste changes. Only 13 people were enrolled before the study was stopped.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for THYROID are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sidney Kimmel Cancer Center at Thomas Jefferson University
Philadelphia, Pennsylvania, 19107, United States
Conditions
Explore the condition pages connected to this study.